Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 6;7(6):695-722.
doi: 10.3390/ph7060695.

Conformational analysis, molecular structure and solid state simulation of the antiviral drug acyclovir (zovirax) using density functional theory methods

Affiliations

Conformational analysis, molecular structure and solid state simulation of the antiviral drug acyclovir (zovirax) using density functional theory methods

Margarita Clara Alvarez-Ros et al. Pharmaceuticals (Basel). .

Abstract

The five tautomers of the drug acyclovir (ACV) were determined and optimised at the MP2 and B3LYP quantum chemical levels of theory. The stability of the tautomers was correlated with different parameters. On the most stable tautomer N1 was carried out a comprehensive conformational analysis, and the whole conformational parameters (R, β, Φ, φ1, φ2, φ3, φ4, φ5) were studied as well as the NBO Natural atomic charges. The calculations were carried out with full relaxation of all geometrical parameters. The search located at least 78 stable structures within 8.5 kcal/mol electronic energy range of the global minimum, and classified in two groups according to the positive or negative value of the torsional angle j1. In the nitrogen atoms and in the O2' and O5' oxygen atoms of the most stable conformer appear a higher reactivity than in the natural nucleoside deoxyguanosine. The solid state was simulated through a dimer and tetramer forms and the structural parameters were compared with the X-ray crystal data available. Several general conclusions were emphasized.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Molecular structure and definition of the torsional angles in tautomer N1 of acyclovir.
Figure 2
Figure 2
Five tautomers described in acyclovir.
Figure 3
Figure 3
Relationship/tendency observed between the relative electronic energy ΔE + ZPE correction of the different tautomers vs. (a) the dipole moment μ. and (b) the exocyclic torsional angle φ1.
Figure 4
Figure 4
Geometry of the six most optimum conformers selected for each rotation angle φ1 determined in A1 conformer of N1 tautomer of acyclovir at B3LYP/6-31G(d,p) level. The values of the strongest intramolecular H-bonds are also included.
Figure 5
Figure 5
Natural atomic charges and optimum bond lengths in conformer B2 of tautomer N1 of acyclovir at B3LYP/6-31G(d,p) and MP2/6-31G(d,p) levels, in fuchsia and green colours, respectively.
Figure 6
Figure 6
Distribution of the 78 optimum stable calculated conformers at the B3LYP/6-31G(d,p) level in tautomer N1 of acyclovir according to their exocyclic torsional angle φ1 and their: (a) relative electronic energy ΔE + ZPE correction; (b) relative Gibbs energy ΔG; and (c) the distance R. The most stable conformers of each type are pointed.
Figure 7
Figure 7
Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir, according to the values of the exocyclic torsional angles: φ2. φ3. φ4 and φ5 versus the angle φ1.
Figure 8
Figure 8
Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir according to the values of the angles Φ and β, and the dipole moment μ versus the angle φ1.
Figure 9
Figure 9
3D plots with the relative energies of the 78 optimum stable conformers according to the values of the exocyclic torsional angles: φ1. φ2. φ3 and φ4 versus relative electronic energy ΔE + ZPE.
Figure 10
Figure 10
The optimized dimer and tetramer forms in conformer A1 of acyclovir at the B3LYP/6-31G(d,p) level. The H-bonds observed are in Å and the E (RB+HF-LYP) in a. u.

References

    1. Schloemer G.C., Han Y.-K., Harrington P.J. Preparation of acyclovir using 1,3-dioxolane. 5567816. U.S. Patent. 1996 Oct 22;
    1. Lazrek H.B., Baddi L., Smietana M., Vasseur J.-J., Sebti S., Zahouily M. One-pot synthesis of antiviral acyclovir and other nucleosides derivatives using doped natural phosphate as Lewis acid catalyst. Nucleos. Nucleot. Nucleic Acids. 2008;27:1107–1112. doi: 10.1080/15257770802341285. - DOI - PubMed
    1. Gao H., Mitra A.K. Synthesis of acyclovir, ganciclovir and their prodrugs: A review. Synthesis. 2000;3:329–351.
    1. De Clercq E. Antiviral drugs: Current state of the art. J. Clinical Virol. 2001;22:73–89. doi: 10.1016/S1386-6532(01)00167-6. - DOI - PubMed
    1. Emmert D.H., Lancaster M.D. Treatment of common cutaneous herpes simplex virus infections. Am. Fam. Physician. 2000;61:1697–1607. - PubMed

LinkOut - more resources